Global Meningococcal Vaccine Market Growth 2019-2024

Publisher Name :
Date: 12-Feb-2019
No. of pages: 161

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate the market size for manufacturers, regions segments, product segments and applications.

The market estimations in this report are based on the marketed sale price of Meningococcal Vaccine. The percentage splits, Market Share, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Meningococcal Vaccine market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report.

According to this study, over the next five years the Meningococcal Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Meningococcal Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Vaccine market by product type, application, key manufacturers and key regions and countries.

This study considers the Meningococcal Vaccine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

- Quadrivalent

- Bivalent

- Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

- Pneumonia

- Meningitis

- Bacteremia

- Others (Arthritis, Conjunctivitis, Urethritis)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Novartis

- GSK

- Merck

- CSL

- Baxter

- JN International Medical Corporation

- Serum Institute of India

- Bio-Med

- China National Biotec Group

- Hualan Bio

- Walvax

- Zhifei

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Meningococcal Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

- To understand the structure of Meningococcal Vaccine market by identifying its various subsegments.

- Focuses on the key global Meningococcal Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Meningococcal Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Meningococcal Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Meningococcal Vaccine Market Growth 2019-2024

Table of Contents

2019-2024 Global Meningococcal Vaccine Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meningococcal Vaccine Consumption 2014-2024
2.1.2 Meningococcal Vaccine Consumption CAGR by Region
2.2 Meningococcal Vaccine Segment by Type
2.2.1 Quadrivalent
2.2.2 Bivalent
2.2.3 Others
2.3 Meningococcal Vaccine Consumption by Type
2.3.1 Global Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2014-2019)
2.3.3 Global Meningococcal Vaccine Sale Price by Type (2014-2019)
2.4 Meningococcal Vaccine Segment by Application
2.4.1 Pneumonia
2.4.2 Meningitis
2.4.3 Bacteremia
2.4.4 Others (Arthritis, Conjunctivitis, Urethritis)
2.5 Meningococcal Vaccine Consumption by Application
2.5.1 Global Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
2.5.2 Global Meningococcal Vaccine Value and Market Share by Application (2014-2019)
2.5.3 Global Meningococcal Vaccine Sale Price by Application (2014-2019)

3 Global Meningococcal Vaccine by Players
3.1 Global Meningococcal Vaccine Sales Market Share by Players
3.1.1 Global Meningococcal Vaccine Sales by Players (2017-2019)
3.1.2 Global Meningococcal Vaccine Sales Market Share by Players (2017-2019)
3.2 Global Meningococcal Vaccine Revenue Market Share by Players
3.2.1 Global Meningococcal Vaccine Revenue by Players (2017-2019)
3.2.2 Global Meningococcal Vaccine Revenue Market Share by Players (2017-2019)
3.3 Global Meningococcal Vaccine Sale Price by Players
3.4 Global Meningococcal Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Meningococcal Vaccine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Meningococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Meningococcal Vaccine by Regions
4.1 Meningococcal Vaccine by Regions
4.1.1 Global Meningococcal Vaccine Consumption by Regions
4.1.2 Global Meningococcal Vaccine Value by Regions
4.2 Americas Meningococcal Vaccine Consumption Growth
4.3 APAC Meningococcal Vaccine Consumption Growth
4.4 Europe Meningococcal Vaccine Consumption Growth
4.5 Middle East & Africa Meningococcal Vaccine Consumption Growth

5 Americas
5.1 Americas Meningococcal Vaccine Consumption by Countries
5.1.1 Americas Meningococcal Vaccine Consumption by Countries (2014-2019)
5.1.2 Americas Meningococcal Vaccine Value by Countries (2014-2019)
5.2 Americas Meningococcal Vaccine Consumption by Type
5.3 Americas Meningococcal Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Meningococcal Vaccine Consumption by Countries
6.1.1 APAC Meningococcal Vaccine Consumption by Countries (2014-2019)
6.1.2 APAC Meningococcal Vaccine Value by Countries (2014-2019)
6.2 APAC Meningococcal Vaccine Consumption by Type
6.3 APAC Meningococcal Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Meningococcal Vaccine by Countries
7.1.1 Europe Meningococcal Vaccine Consumption by Countries (2014-2019)
7.1.2 Europe Meningococcal Vaccine Value by Countries (2014-2019)
7.2 Europe Meningococcal Vaccine Consumption by Type
7.3 Europe Meningococcal Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Meningococcal Vaccine by Countries
8.1.1 Middle East & Africa Meningococcal Vaccine Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Meningococcal Vaccine Value by Countries (2014-2019)
8.2 Middle East & Africa Meningococcal Vaccine Consumption by Type
8.3 Middle East & Africa Meningococcal Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Meningococcal Vaccine Distributors
10.3 Meningococcal Vaccine Customer

11 Global Meningococcal Vaccine Market Forecast
11.1 Global Meningococcal Vaccine Consumption Forecast (2019-2024)
11.2 Global Meningococcal Vaccine Forecast by Regions
11.2.1 Global Meningococcal Vaccine Forecast by Regions (2019-2024)
11.2.2 Global Meningococcal Vaccine Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Meningococcal Vaccine Forecast by Type
11.8 Global Meningococcal Vaccine Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Company Details
12.1.2 Meningococcal Vaccine Product Offered
12.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Novartis News
12.2 GSK
12.2.1 Company Details
12.2.2 Meningococcal Vaccine Product Offered
12.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 GSK News
12.3 Merck
12.3.1 Company Details
12.3.2 Meningococcal Vaccine Product Offered
12.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Merck News
12.4 CSL
12.4.1 Company Details
12.4.2 Meningococcal Vaccine Product Offered
12.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 CSL News
12.5 Baxter
12.5.1 Company Details
12.5.2 Meningococcal Vaccine Product Offered
12.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Baxter News
12.6 JN International Medical Corporation
12.6.1 Company Details
12.6.2 Meningococcal Vaccine Product Offered
12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 JN International Medical Corporation News
12.7 Serum Institute of India
12.7.1 Company Details
12.7.2 Meningococcal Vaccine Product Offered
12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Serum Institute of India News
12.8 Bio-Med
12.8.1 Company Details
12.8.2 Meningococcal Vaccine Product Offered
12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Bio-Med News
12.9 China National Biotec Group
12.9.1 Company Details
12.9.2 Meningococcal Vaccine Product Offered
12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 China National Biotec Group News
12.10 Hualan Bio
12.10.1 Company Details
12.10.2 Meningococcal Vaccine Product Offered
12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Hualan Bio News
12.11 Walvax
12.12 Zhifei

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Meningococcal Vaccine
Table Product Specifications of Meningococcal Vaccine
Figure Meningococcal Vaccine Report Years Considered
Figure Market Research Methodology
Figure Global Meningococcal Vaccine Consumption Growth Rate 2014-2024 (K Dose)
Figure Global Meningococcal Vaccine Value Growth Rate 2014-2024 ($ Millions)
Table Meningococcal Vaccine Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Quadrivalent
Table Major Players of Quadrivalent
Figure Product Picture of Bivalent
Table Major Players of Bivalent
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2014-2019)
Table Global Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure Global Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Table Global Meningococcal Vaccine Revenue by Type (2014-2019) ($ million)
Table Global Meningococcal Vaccine Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Meningococcal Vaccine Value Market Share by Type (2014-2019)
Table Global Meningococcal Vaccine Sale Price by Type (2014-2019)
Figure Meningococcal Vaccine Consumed in Pneumonia
Figure Global Meningococcal Vaccine Market: Pneumonia (2014-2019) (K Dose)
Figure Global Meningococcal Vaccine Market: Pneumonia (2014-2019) ($ Millions)
Figure Global Pneumonia YoY Growth ($ Millions)
Figure Meningococcal Vaccine Consumed in Meningitis
Figure Global Meningococcal Vaccine Market: Meningitis (2014-2019) (K Dose)
Figure Global Meningococcal Vaccine Market: Meningitis (2014-2019) ($ Millions)
Figure Global Meningitis YoY Growth ($ Millions)
Figure Meningococcal Vaccine Consumed in Bacteremia
Figure Global Meningococcal Vaccine Market: Bacteremia (2014-2019) (K Dose)
Figure Global Meningococcal Vaccine Market: Bacteremia (2014-2019) ($ Millions)
Figure Global Bacteremia YoY Growth ($ Millions)
Figure Meningococcal Vaccine Consumed in Others (Arthritis, Conjunctivitis, Urethritis)
Figure Global Meningococcal Vaccine Market: Others (Arthritis, Conjunctivitis, Urethritis) (2014-2019) (K Dose)
Figure Global Meningococcal Vaccine Market: Others (Arthritis, Conjunctivitis, Urethritis) (2014-2019) ($ Millions)
Figure Global Others (Arthritis, Conjunctivitis, Urethritis) YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure Global Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Table Global Meningococcal Vaccine Value by Application (2014-2019)
Table Global Meningococcal Vaccine Value Market Share by Application (2014-2019)
Figure Global Meningococcal Vaccine Value Market Share by Application (2014-2019)
Table Global Meningococcal Vaccine Sale Price by Application (2014-2019)
Table Global Meningococcal Vaccine Sales by Players (2017-2019) (K Dose)
Table Global Meningococcal Vaccine Sales Market Share by Players (2017-2019)
Figure Global Meningococcal Vaccine Sales Market Share by Players in 2017
Figure Global Meningococcal Vaccine Sales Market Share by Players in 2018
Table Global Meningococcal Vaccine Revenue by Players (2017-2019) ($ Millions)
Table Global Meningococcal Vaccine Revenue Market Share by Players (2017-2019)
Figure Global Meningococcal Vaccine Revenue Market Share by Players in 2017
Figure Global Meningococcal Vaccine Revenue Market Share by Players in 2018
Table Global Meningococcal Vaccine Sale Price by Players (2017-2019)
Figure Global Meningococcal Vaccine Sale Price by Players in 2018
Table Global Meningococcal Vaccine Manufacturing Base Distribution and Sales Area by Players
Table Players Meningococcal Vaccine Products Offered
Table Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Meningococcal Vaccine Consumption by Regions 2014-2019 (K Dose)
Table Global Meningococcal Vaccine Consumption Market Share by Regions 2014-2019
Figure Global Meningococcal Vaccine Consumption Market Share by Regions 2014-2019
Table Global Meningococcal Vaccine Value by Regions 2014-2019 ($ Millions)
Table Global Meningococcal Vaccine Value Market Share by Regions 2014-2019
Figure Global Meningococcal Vaccine Value Market Share by Regions 2014-2019
Figure Americas Meningococcal Vaccine Consumption 2014-2019 (K Dose)
Figure Americas Meningococcal Vaccine Value 2014-2019 ($ Millions)
Figure APAC Meningococcal Vaccine Consumption 2014-2019 (K Dose)
Figure APAC Meningococcal Vaccine Value 2014-2019 ($ Millions)
Figure Europe Meningococcal Vaccine Consumption 2014-2019 (K Dose)
Figure Europe Meningococcal Vaccine Value 2014-2019 ($ Millions)
Figure Middle East & Africa Meningococcal Vaccine Consumption 2014-2019 (K Dose)
Figure Middle East & Africa Meningococcal Vaccine Value 2014-2019 ($ Millions)
Table Americas Meningococcal Vaccine Consumption by Countries (2014-2019) (K Dose)
Table Americas Meningococcal Vaccine Consumption Market Share by Countries (2014-2019)
Figure Americas Meningococcal Vaccine Consumption Market Share by Countries in 2018
Table Americas Meningococcal Vaccine Value by Countries (2014-2019) ($ Millions)
Table Americas Meningococcal Vaccine Value Market Share by Countries (2014-2019)
Figure Americas Meningococcal Vaccine Value Market Share by Countries in 2018
Table Americas Meningococcal Vaccine Consumption by Type (2014-2019) (K Dose)
Table Americas Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure Americas Meningococcal Vaccine Consumption Market Share by Type in 2018
Table Americas Meningococcal Vaccine Consumption by Application (2014-2019) (K Dose)
Table Americas Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure Americas Meningococcal Vaccine Consumption Market Share by Application in 2018
Figure United States Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure United States Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Canada Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Canada Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Mexico Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Mexico Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Table APAC Meningococcal Vaccine Consumption by Countries (2014-2019) (K Dose)
Table APAC Meningococcal Vaccine Consumption Market Share by Countries (2014-2019)
Figure APAC Meningococcal Vaccine Consumption Market Share by Countries in 2018
Table APAC Meningococcal Vaccine Value by Countries (2014-2019) ($ Millions)
Table APAC Meningococcal Vaccine Value Market Share by Countries (2014-2019)
Figure APAC Meningococcal Vaccine Value Market Share by Countries in 2018
Table APAC Meningococcal Vaccine Consumption by Type (2014-2019) (K Dose)
Table APAC Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure APAC Meningococcal Vaccine Consumption Market Share by Type in 2018
Table APAC Meningococcal Vaccine Consumption by Application (2014-2019) (K Dose)
Table APAC Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure APAC Meningococcal Vaccine Consumption Market Share by Application in 2018
Figure China Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure China Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Japan Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Japan Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Korea Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Korea Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Southeast Asia Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure India Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure India Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Australia Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Australia Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Table Europe Meningococcal Vaccine Consumption by Countries (2014-2019) (K Dose)
Table Europe Meningococcal Vaccine Consumption Market Share by Countries (2014-2019)
Figure Europe Meningococcal Vaccine Consumption Market Share by Countries in 2018
Table Europe Meningococcal Vaccine Value by Countries (2014-2019) ($ Millions)
Table Europe Meningococcal Vaccine Value Market Share by Countries (2014-2019)
Figure Europe Meningococcal Vaccine Value Market Share by Countries in 2018
Table Europe Meningococcal Vaccine Consumption by Type (2014-2019) (K Dose)
Table Europe Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure Europe Meningococcal Vaccine Consumption Market Share by Type in 2018
Table Europe Meningococcal Vaccine Consumption by Application (2014-2019) (K Dose)
Table Europe Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure Europe Meningococcal Vaccine Consumption Market Share by Application in 2018
Figure Germany Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Germany Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure France Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure France Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure UK Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure UK Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Italy Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Italy Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Russia Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Russia Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Spain Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Spain Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Meningococcal Vaccine Consumption by Countries (2014-2019) (K Dose)
Table Middle East & Africa Meningococcal Vaccine Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Meningococcal Vaccine Consumption Market Share by Countries in 2018
Table Middle East & Africa Meningococcal Vaccine Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Meningococcal Vaccine Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Meningococcal Vaccine Value Market Share by Countries in 2018
Table Middle East & Africa Meningococcal Vaccine Consumption by Type (2014-2019) (K Dose)
Table Middle East & Africa Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Meningococcal Vaccine Consumption Market Share by Type in 2018
Table Middle East & Africa Meningococcal Vaccine Consumption by Application (2014-2019) (K Dose)
Table Middle East & Africa Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Meningococcal Vaccine Consumption Market Share by Application in 2018
Figure Egypt Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Egypt Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure South Africa Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure South Africa Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Israel Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Israel Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Turkey Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Turkey Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure GCC Countries Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Table Meningococcal Vaccine Distributors List
Table Meningococcal Vaccine Customer List
Figure Global Meningococcal Vaccine Consumption Growth Rate Forecast (2019-2024) (K Dose)
Figure Global Meningococcal Vaccine Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Meningococcal Vaccine Consumption Forecast by Countries (2019-2024) (K Dose)
Table Global Meningococcal Vaccine Consumption Market Forecast by Regions
Table Global Meningococcal Vaccine Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Meningococcal Vaccine Value Market Share Forecast by Regions
Figure Americas Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Americas Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure APAC Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure APAC Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Europe Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Europe Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Middle East & Africa Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Middle East & Africa Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure United States Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure United States Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Canada Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Canada Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Mexico Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Mexico Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Brazil Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Brazil Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure China Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure China Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Japan Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Japan Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Korea Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Korea Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Southeast Asia Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Southeast Asia Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure India Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure India Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Australia Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Australia Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Germany Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Germany Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure France Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure France Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure UK Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure UK Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Italy Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Italy Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Russia Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Russia Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Spain Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Spain Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Egypt Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Egypt Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure South Africa Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure South Africa Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Israel Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Israel Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Turkey Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Turkey Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure GCC Countries Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure GCC Countries Meningococcal Vaccine Value 2019-2024 ($ Millions)
Table Global Meningococcal Vaccine Consumption Forecast by Type (2019-2024) (K Dose)
Table Global Meningococcal Vaccine Consumption Market Share Forecast by Type (2019-2024)
Table Global Meningococcal Vaccine Value Forecast by Type (2019-2024) ($ Millions)
Table Global Meningococcal Vaccine Value Market Share Forecast by Type (2019-2024)
Table Global Meningococcal Vaccine Consumption Forecast by Application (2019-2024) (K Dose)
Table Global Meningococcal Vaccine Consumption Market Share Forecast by Application (2019-2024)
Table Global Meningococcal Vaccine Value Forecast by Application (2019-2024) ($ Millions)
Table Global Meningococcal Vaccine Value Market Share Forecast by Application (2019-2024)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Novartis Meningococcal Vaccine Market Share (2017-2019)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure GSK Meningococcal Vaccine Market Share (2017-2019)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Merck Meningococcal Vaccine Market Share (2017-2019)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure CSL Meningococcal Vaccine Market Share (2017-2019)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Baxter Meningococcal Vaccine Market Share (2017-2019)
Table JN International Medical Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure JN International Medical Corporation Meningococcal Vaccine Market Share (2017-2019)
Table Serum Institute of India Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Serum Institute of India Meningococcal Vaccine Market Share (2017-2019)
Table Bio-Med Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bio-Med Meningococcal Vaccine Market Share (2017-2019)
Table China National Biotec Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure China National Biotec Group Meningococcal Vaccine Market Share (2017-2019)
Table Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Hualan Bio Meningococcal Vaccine Market Share (2017-2019)
Table Walvax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zhifei Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Global Becker Muscular Dystrophy Drug Market Professional Survey Report 2019
    Published: 14-Oct-2019        Price: US 3500 Onwards        Pages: 100
    The global Becker Muscular Dystrophy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Becker Muscular Dystrophy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Becker Muscular Dystrophy Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes ......
  • Global Prazosin Hydrochloride (CAS 19237-84-4) Market Professional Survey Report 2019
    Published: 14-Oct-2019        Price: US 3500 Onwards        Pages: 100
    The global Prazosin Hydrochloride (CAS 19237-84-4) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Prazosin Hydrochloride (CAS 19237-84-4) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prazosin Hydrochloride (CAS 19237-84-4) market size by analyzing historical data and future prospect. Regionall......
  • Global and China Botulinum Toxins Market Research by Company, Type & Application 2013-2025
    Published: 12-Oct-2019        Price: US 2000 Onwards        Pages: 69
    Summary Market Segment as follows: By Type - Botulinum Toxins A - Botulinum Toxins B - Botulinum Toxins C - Botulinum Toxins D - Botulinum Toxins E - Others By Application - Cosmetic Use - Medical Use - Research Use By Company - Allergan - Ipsen - Merz - Medytox Inc - US WorldMeds - LIBP The main contents of the report includi......
  • Global and China Primary Biliary Cirrhosis Drug Market Research by Company, Type & Application 2013-2025
    Published: 12-Oct-2019        Price: US 2000 Onwards        Pages: 79
    Summary Market Segment as follows: By Type - Budesonide - FFP-104 - GSK-2330672 - MBX-8025 - NGM-282 - Others By Application - Clinic - Hospital - Others By Company - AlbireoPharma - CymaBay Therapeutics, Inc. - Dr. Falk Pharma GmbH - Enanta Pharmaceuticals, Inc. - GlaxoSmithKline Plc - Intercept Pharmaceuticals, Inc. - Johnson & John......
  • Global and China Capecitabine Fumarate Market Research by Company, Type & Application 2013-2025
    Published: 11-Oct-2019        Price: US 2000 Onwards        Pages: 72
    Summary Market Segment as follows: By Type - Capecitabine Fumarate Oral - Capecitabine Fumarate Infusion By Application - Breast Cancer - Rectal Cancer - Colon Cancer - Gastric Cancer - Other Malignancies By Company - Novartis - Sun Pharma Global - Pfizer - Dr Reddys - Mylan - Sagent Pharms - Akorn - Emcure Pharms - Hikma Farmaceutica......
  • Global Travel Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 11-Oct-2019        Price: US 3480 Onwards        Pages: 108
    Scope of the Report: The worldwide market for Travel Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Travel Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manuf......
  • Global and China Antacid Tablet Market Research by Company, Type & Application 2013-2025
    Published: 11-Oct-2019        Price: US 2000 Onwards        Pages: 81
    Summary Market Segment as follows: By Type - Ca based - Mg based - Mixed By Application - In-Patient - Out-Patient By Company - GSK - Walmart Equate - Boehringer Ingelheim Pharmaceuticals - Chattem - Bayer - WellSpring Pharmaceutical Corporation - Thornton & Ross Ltd - PG - McNeil Consumer Pharmaceuticals The main contents of the rep......
  • Global and China Albendazole Market Research by Company, Type & Application 2013-2025
    Published: 11-Oct-2019        Price: US 2000 Onwards        Pages: 75
    Summary Market Segment as follows: By Type - Capsule - Tablet By Application - Pinworm Infection Treatment - Ascaris Infection Treatment - Other Parasitic Infections Treatment By Company - CHANGZHOU YABANG - GlaxoSmithKline - Huazhong Pharmaceutical - Hubei Zhongjia-chem Pharmaceutical - HUBEI KEYI - Sequent Scientifi - Lasa Laboratory Pvt Ltd - K.A.Malle......
  • Generic Drugs Companies in China
    Published: 11-Oct-2019        Price: US 1800 Onwards        Pages: 56
    This study focuses on China's Generic Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of go......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs